IL1RN and allergic asthma: This finding coincides with a previous report that serum from asthmatic mice potentiates the therapeutic effects of MSCs in experimental allergic asthma and increased the expression of various mediators, including TGF-β, IFN-γ, IL-10, TSG-6, IDO-1, and IL-1RN [37].